Scroll To Top
Search by Speciality

2015 EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO SYMPOSIUM) ON IMMUNO-ONCOLOGY

MCH Beaulieu Lausanne SA | Lausanne, SWITZERLAND
From 100 to 300 EUR
Event Preview
EXPIRED
This event
is Finished
Title: 2015 EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO SYMPOSIUM) ON IMMUNO-ONCOLOGY
Specialty: Medical Oncology, Immunology
Dates: From Nov, 20, 2015 to Nov, 21, 2015
Location: Lausanne, SWITZERLAND
Type: Symposium
Registration Cost: From 100 to 300 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Nov
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for LAUSANNE, Switzerland.
General Info
Event Venue:

MCH Beaulieu Lausanne SA

LAUSANNE, SWITZERLAND Visit the Venue to read more
Currency:
EUR
Accreditation:

-

The programme will also be submitted for accreditation to the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found online here.
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Major themes


Checkpoint inhibition

Cancer neo-antigens

Immunomodulatory antibodies

PD-1/PD-L1 axis blockade, results to date

Immuno-oncology meets molecular oncology

Adoptive T cell therapy

Immuno-Oncology clinical studies across tumour types (breast, lung, brain, gastrointestinal, genitourinary, gynaecology, melanoma, lymphoma)



ESMO-MORA: The Symposium programme will be submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possesses the necessary skills and standards for the practice of medical oncology. See here for further details.

Registration Needs updating Register Now
Currency:

EUR

Registration Cost
Type
Early Registration

2015-09-30
Late Registration From: 2015-11-04 To: 2015-11-05
On site Registration
Non Member fee
200
250
300
ESMO Member fee
100
150
300

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:
Congrès Beaulieu Lausanne


MCH Beaulieu Lausanne SA


Avenue des Bergières 10


1000 Lausanne 22

www.congres-lausanne.ch

Scientific Content Up to Date
Submission Info

The Symposium Scientific Committee is calling for abstract submission in the following sub-specialties:


Checkpoint inhibition

Cancer neo-antigens

Immunomodulatory antibodies

PD-1/PD-L1 axis blockade

Immuno-oncology meets molecular oncology

Adoptive T cell therapy

Immuno-oncology clinical studies across tumour types (breast, lung, brain, gastrointestinal, genitourinary, gynaecology, melanoma, lymphoma)

Trials in progress


Trial in Progress abstracts in all phases of clinical research (phases I to III) may be submitted.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:


Background

Trial design

Notes:


Recruitment must have already begun or have been completed by the abstract submission deadline of 8 September 2015.

Abstracts including results or preliminary data will be rejected.

Trial in Progress abstracts may not be considered for Proffered Paper (oral) presentation.


Presentation and publication of accepted abstracts


The ESMO Symposium on Immuno-Oncology 2015 Scientific Committee will select abstracts for presentation during the Symposium and determine the format of the presentations from the following possibilities:


Poster Discussion – Presentation and analysis by an invited speaker highlighting important findings within a disease type or about a common theme plus interactive audience discussion.

Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Symposium.

All accepted abstracts will be published in the ESMO Symposium on Immuno-Oncology 2015 Abstract Book.

Sponsors Exhibitors
General Info

Daura , Ms. , ESMO

Phone: 011-41-91-973-1900

Fax: 011-41-91-973-1902

Contact
Organising Agency

Daura , Ms. , ESMO

Phone: 011-41-91-973-1900

Fax: 011-41-91-973-1902

Event map
Revelant Events